CRMD
NASDAQ · Pharmaceuticals
Cormedix Inc
$7.44
-0.07 (-0.93%)
Open$7.58
Previous Close$7.51
Day High$7.59
Day Low$7.40
52W High$14.96
52W Low$6.13
Volume—
Avg Volume907.0K
Market Cap589.17M
P/E Ratio3.25
EPS$2.10
SectorPharmaceuticals
Analyst Ratings
Strong Buy
11 analysts
Price Target
+605.6% upside
Current
$7.44
$7.44
Target
$52.50
$52.50
$41.99
$52.50 avg
$66.46
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 305.32M | 151.82M | 142.81M |
| Net Income | 159.71M | 25.07M | 23.58M |
| Profit Margin | 52.3% | 16.5% | 16.5% |
| EBITDA | 147.73M | 47.08M | 40.68M |
| Free Cash Flow | — | 14.58M | 22.25M |
| Rev Growth | +1,545.2% | +9.9% | -6.7% |
| Debt/Equity | 0.36 | 0.10 | 0.09 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |